The JAK2 and IL6/JAK2/STAT3 signaling pathways are therapeutic targets for treating excessive inflammatory response to virus infection, where PIK3CB, the target of miRNA−34a participated in TCR−mediated NF−κB signaling after binding to B7 ligand on antigen presenting cells (APC). Here, NFKB1 is linked to viral infectious disease.